Hantz Financial Services, Inc. Vista Gen Therapeutics, Inc. Put Options Transaction History
Hantz Financial Services, Inc.
- $5.2 Billion
- Q2 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding VTGN
# of Institutions
2Shares Held
2.7MCall Options Held
0Put Options Held
0About VistaGen Therapeutics, Inc.
- Ticker VTGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 206,836,000
- Market Cap $645M
- Description
- VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III d...